CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares traded.
CardioGenics Stock Down 100.0 %
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Featured Articles
- Five stocks we like better than CardioGenics
- Quiet Period Expirations Explained
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Stocks to Buy While Others Stay on the Sidelines
- How to Calculate Options Profits
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
